Sensus Healthcare Inc
SRTS
Company Profile
Business description
Sensus Healthcare Inc is engaged in manufacturing a superficial radiotherapy system. These devices are used for treating both oncological and non-oncological skin conditions including basal cell and squamous cell skin cancers and other skin conditions such as keloids. Its product includes SRT-100, SRT-100 vision, and a sentinel service program. The company's revenue is generated majorly from customers in the United States.
Contact
851 Broken Sound Parkway, NW
Suite 215
Boca RatonFL33487
USAT: +1 561 922-5808
Sector
Healthcare
Stock type
Defensive
Industry
Medical Devices
Fiscal Year End
31 December 2026
Employees
60
Stocks News & Analysis
stocks
What did Morningstar subscribers buy and sell during June?
ETFs took centre stage in June alongside renewed interest in beaten down growth names.
stocks
Australia’s largest gold miner downgraded on a falling gold price
A cooling gold price sees fair value cuts across the board.
stocks
Cheap ASX share pays a heavy price for NRL rights
Growth has slowed amid increased competition for viewers and content.
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,001.30 | 3.70 | 0.04% |
| CAC 40 | 8,366.85 | 2.20 | 0.03% |
| DAX 40 | 25,144.38 | 30.13 | 0.12% |
| Dow JONES (US) | 52,414.61 | 84.03 | -0.16% |
| FTSE 100 | 10,529.39 | 31.10 | 0.30% |
| HKSE | 24,340.73 | 127.01 | 0.52% |
| NASDAQ | 26,112.88 | 239.71 | 0.93% |
| Nikkei 225 | 67,743.50 | 500.77 | 0.74% |
| NZX 50 Index | 13,651.22 | 71.98 | -0.52% |
| S&P 500 | 7,542.83 | 27.49 | 0.37% |
| S&P/ASX 200 | 8,808.50 | 4.80 | 0.05% |
| SSE Composite Index | 3,967.13 | 53.33 | 1.36% |